All the procedures were approved and performed in compliance with the regional ethics committee (protocol (#17858 and #32499, CEEA-Pays de la Loire, France) according to Directive 2010/63/EU of the European Union. The reporting is in accordance with current ARRIVE guidelines and the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (NIH Pub. No. 85-23, revised 2011).
1. Ethical status and general information on rats
2. Room set-up and preparation steps
3. Preparing the rat for surgery
4. Jugular vein cannulation
5. Femoral artery cannulation
6. Hemorrhagic shock protocol (Figure 1)
7. End of surgery and recovery and post-surgical follow-up
Figure 1: Model of mixed rat hemorrhagic shock. Created with BioRender.com Please click here to view a larger version of this figure.
8. 24 h after hemorrhagic shock induction
Following the protocol described above, we evaluated several hemodynamics parameters 24 hours after the induction of the hemorrhagic shock. Basal mean arterial pressure (before the start of the hemorrhagic shock protocol) is similar between the sham and hemorrhagic shock groups (Figure 2A). As expected, the mean arterial pressure is significantly decreased with the hemorrhagic shock protocol, which can be explained by the drop in the diastolic blood pressure (Mean arterial pressure: Sham: 92 mmHg ± 3 mmHg; HS: 82 mmHg ± 2 mmHg; Diastolic blood pressure: 73 mmHg ± 3 mmHg; HS: 61 mmHg ± 2 mmHg) (Figure 2B, C). Hemorrhagic shock does not impact systolic blood pressure, pulse pressure, and heart rate (Figure 2D–F). The shock index (heart rate/systolic blood pressure ratio) and the modified shock index (MSI) (heart rate/mean blood pressure ratio) are two predictors of mortality in severe patients14,15. The higher the values are, the greater the risk of mortality. In this model, the shock index is unmodified between the two groups, while the modified shock index tends to increase in the hemorrhagic shock (MSI: Sham: 4.24 ± 0.11; HS: 4.70 ± 0.15) (Figure 2G,H).
Figure 2: Impact of hemorrhagic shock on hemodynamics parameters. (A) Basal mean arterial pressure, (B) mean arterial pressure, (C) diastolic blood pressure, (D) systolic blood pressure, (E) pulse pressure, (F) heart rate, (G) shock index, and (H) modified shock index between Sham and hemorrhagic shock animals. Results are represented as mean ± SEM. Statistical significance was assessed by unpaired t-test. *: p < 0.05; ***: p < 0.001. n = 6-12. Please click here to view a larger version of this figure.
Global metabolic impairment during hemorrhagic shock can be assessed by lactatemia. As expected, the lactatemia increased after the hemorrhagic shock protocol and 16 h after (End of protocol: Sham: 1.13 mmol/L ± 0.14 mmol/L; HS: 5.98 mmol/L ± 0.39 mmol/L; H+16: Sham: 1.95 mmol/L ± 0.23 mmol/L; HS: 2.95 mmol/L ± 0.19 mmol/L) (Figure 3A,B). Temperature and respiration rate are two components of the Systemic Inflammatory Response Syndrome (SIRS), a pro-inflammatory response characteristic of the state of shock. Neither temperature nor respiration rate are modified between the two groups 16 h after the hemorrhagic shock induction (Figure 3C,D). We evaluated the impact of the hemorrhagic shock on a few behavior parameters like posture, activity, etc. (Supplementary File 1). The behavioral score is increased in the hemorrhagic shock group 16 h after the protocol (Sham: 0.33 ± 0.21; HS: 2.27 ± 0.69) (Figure 3E).
Figure 3: Impact of hemorrhagic shock on lactatemia, temperature, respiration rate, and behavioral score. (A) Lactatemia at the end of the hemorrhagic shock protocol, (B) lactatemia, (C) temperature, (D) respiration rate, and (E) behavioral score 16 h after hemorrhagic shock induction between Sham and hemorrhagic shock animals. Results are represented as mean ± SEM. Statistical significance was assessed by unpaired t-test. *: p < 0.05; **: p < 0.01; ***: p < 0.001. n = 6-12. Please click here to view a larger version of this figure.
The hemorrhagic shock is associated with an organ dysfunction. In order to evaluate if the model could be clinically relevant, we assessed plasmatic markers of organ injury 24 h after the protocol. The creatininemia (Sham: 19.13 µmol/L ± 0.33 µmol/L; HS: 28.88 µmol/L ± 2.69 µmol/L), the cardiac troponin T (Sham: 9.38 ng/L ± 1.87 ng/L; HS: 35.62 ng/L ± 2.28 ng/L), and the aspartate and alanine amino transferase (ASAT: Sham: 221 UI/L ± 48 UI/L; HS: 963 UI/L ± 144 UI/L; ALAT: Sham: 36 UI/L ± 4 UI/L; HS: 323 UI/L ± 13 UI/L) which reflect damages to the kidney, heart and liver respectively are all significantly increased with the hemorrhagic shock (Figure 4).
Figure 4: The hemorrhagic shock model is associated with organ dysfunction. (A) Creatininemia, (B) cardiac troponin T, (C) aspartate aminotransferase, and (D) alanine aminotransferase levels 24 h after hemorrhagic shock induction between Sham and hemorrhagic shock animals. Results are represented as mean ± SEM. Statistical significance was assessed by unpaired t-test. *: p < 0.05; **: p < 0.01; ***: p < 0.001. n = 4 Please click here to view a larger version of this figure.
Supplementary file 1: Behavioral score details Please click here to download this File.
1 mL syringe | TERUMO | MDSS01SE | |
2.5 mL syringe | TERUMO | SS*02SE1 | |
20 mL syringe | TERUMO | MDSS20ESE | |
Anesthesia induction chamber | TEMSEGA | HUBBIV4 | |
BD Microlance 3 23 G needle | Becton Dickinson | 300800 | |
BD Microlance 3 26 G needle | Becton Dickinson | 304300 | |
Blood pressure transducer | emka TECHNOLOGIES | BP_T | |
Buprecare | Axience | N/A | 1 mL vial, buprenorphine 0.3 mg/mL |
DE BAKEY, Atraumatic Vascular Forceps | ALLGAIER instrumente medical | 09-543-150 | |
Dermal Betadine 10% | Mylan | N/A | 125 mL bottle |
Fine Forceps – Curved / Serrated | Fine Science Tools | 11065-07 | |
GraphPad Prism 8 | GraphPad by Dotmatics | – | |
Heating mats | TEMSEGA | OPT/THERM_MATELASSTEREORATS | |
Heparin sodium | PANPHARMA | N/A | 5 mL bottle, 5,000 UI/mL |
IOX2 software | emka TECHNOLOGIES | IOX_BASE_4c + IOX_FULLCARDIO_4a | |
Iris Scissors – ToughCut | Fine Science Tools | 14058-11 | |
Lidocaine | Fresenius | N/A | 10 mL bootle, 8.11 mg, lidocaine hydrochloride |
MiniHub-V3.2 | TEMSEGA | PF006 | |
Moria 201/A Vessel Clamp – Straight | Fine Science Tools | 18320-11 | |
Non sterile compresses | Raffin | 70189 | |
Non sterile drape | Dutscher | 30786 | |
Olsen-Hegar Needle Holder with Scissors | Fine Science Tools | 12002-12 | |
Polyethylene tubing PE10 | PHYMEP | BTPE-10 | |
Polyethylene tubing PE50 | PHYMEP | BTPE-50 | |
Rats | Charles Rivers | – | Male WISTAR HAN (10 weeks) |
Rectal probe | TEMSEGA | SONDE_TEMP_RATS | |
Ringer Lactates | Fresenius Kabi | 964175 | |
Scrub Betadine 4% | Mylan | N/A | 125 mL bottle |
Sevoflurane | Abbott | N/A | 250 mL bottle, gas 100% |
Sevoflurane Vaporizer | TEMSEGA | SEVOTEC3NSELEC | |
StatStrip lactate test strips | Nova Biomedical | 47486 | |
StatStrip Xpress lactate Meter | Nova Biomedical | 47486 | |
Sterile compresses | Laboratoire SYLAMED | 211S05-50 | |
Sterile drape | Mölnlycke | 800330 | |
Steriles gloves | MEDLINE | MSG7275 | |
Suture | Optilene | 3097141 | |
Suture for vessels | SMI | 8150046 | |
Syringe pump | Vial médical | 16010 | |
usbAMP | emka TECHNOLOGIES | – | |
Vannas Spring Scissors | Fine Science Tools | 15000-00 | |
Vaseline | Cooper | N/A | 10 mL vial |
Vitamin A Dulcis (ALLERGAN) | Allergan | N/A | 10 g tube, Retinol |
Over the recent decades, the development of animal models allowed us to better understand various pathologies and identify new treatments. Hemorrhagic shock, i.e., organ failure due to rapid loss of a large volume of blood, is associated with a highly complex pathophysiology involving several pathways. Numerous existing animal models of hemorrhagic shock strive to replicate what happens in humans, but these models have limits in terms of clinical relevance, reproducibility, or standardization. The aim of this study was to refine these models to develop a new model of hemorrhagic shock. Briefly, hemorrhagic shock was induced in male Wistar Han rats (11-13 weeks old) by a controlled exsanguination responsible for a drop in the mean arterial pressure. The next phase of 75 min was to maintain a low mean arterial blood pressure, between 32 mmHg and 38 mmHg, to trigger the pathophysiological pathways of hemorrhagic shock. The final phase of the protocol mimicked patient care with an administration of intravenous fluids, Ringer Lactate solution, to elevate the blood pressure. Lactate and behavioral scores were assessed 16 h after the protocol started, while hemodynamics parameters and plasmatic markers were evaluated 24 h after injury. Twenty-four hours post-hemorrhagic shock induction, the mean arterial and diastolic blood pressure were decreased in the hemorrhagic shock group (p < 0.05). Heart rate and systolic blood pressure remained unchanged. All organ damage markers were increased with the hemorrhagic shock (p < 0.05). The lactatemia and behavioral scores were increased compared to the sham group (p < 0.05). In conclusion, we demonstrated that the protocol described here is a relevant model of hemorrhagic shock that can be used in subsequent studies, particularly to evaluate the therapeutic potential of new molecules.
Over the recent decades, the development of animal models allowed us to better understand various pathologies and identify new treatments. Hemorrhagic shock, i.e., organ failure due to rapid loss of a large volume of blood, is associated with a highly complex pathophysiology involving several pathways. Numerous existing animal models of hemorrhagic shock strive to replicate what happens in humans, but these models have limits in terms of clinical relevance, reproducibility, or standardization. The aim of this study was to refine these models to develop a new model of hemorrhagic shock. Briefly, hemorrhagic shock was induced in male Wistar Han rats (11-13 weeks old) by a controlled exsanguination responsible for a drop in the mean arterial pressure. The next phase of 75 min was to maintain a low mean arterial blood pressure, between 32 mmHg and 38 mmHg, to trigger the pathophysiological pathways of hemorrhagic shock. The final phase of the protocol mimicked patient care with an administration of intravenous fluids, Ringer Lactate solution, to elevate the blood pressure. Lactate and behavioral scores were assessed 16 h after the protocol started, while hemodynamics parameters and plasmatic markers were evaluated 24 h after injury. Twenty-four hours post-hemorrhagic shock induction, the mean arterial and diastolic blood pressure were decreased in the hemorrhagic shock group (p < 0.05). Heart rate and systolic blood pressure remained unchanged. All organ damage markers were increased with the hemorrhagic shock (p < 0.05). The lactatemia and behavioral scores were increased compared to the sham group (p < 0.05). In conclusion, we demonstrated that the protocol described here is a relevant model of hemorrhagic shock that can be used in subsequent studies, particularly to evaluate the therapeutic potential of new molecules.
Over the recent decades, the development of animal models allowed us to better understand various pathologies and identify new treatments. Hemorrhagic shock, i.e., organ failure due to rapid loss of a large volume of blood, is associated with a highly complex pathophysiology involving several pathways. Numerous existing animal models of hemorrhagic shock strive to replicate what happens in humans, but these models have limits in terms of clinical relevance, reproducibility, or standardization. The aim of this study was to refine these models to develop a new model of hemorrhagic shock. Briefly, hemorrhagic shock was induced in male Wistar Han rats (11-13 weeks old) by a controlled exsanguination responsible for a drop in the mean arterial pressure. The next phase of 75 min was to maintain a low mean arterial blood pressure, between 32 mmHg and 38 mmHg, to trigger the pathophysiological pathways of hemorrhagic shock. The final phase of the protocol mimicked patient care with an administration of intravenous fluids, Ringer Lactate solution, to elevate the blood pressure. Lactate and behavioral scores were assessed 16 h after the protocol started, while hemodynamics parameters and plasmatic markers were evaluated 24 h after injury. Twenty-four hours post-hemorrhagic shock induction, the mean arterial and diastolic blood pressure were decreased in the hemorrhagic shock group (p < 0.05). Heart rate and systolic blood pressure remained unchanged. All organ damage markers were increased with the hemorrhagic shock (p < 0.05). The lactatemia and behavioral scores were increased compared to the sham group (p < 0.05). In conclusion, we demonstrated that the protocol described here is a relevant model of hemorrhagic shock that can be used in subsequent studies, particularly to evaluate the therapeutic potential of new molecules.